Overview
Hussein Assi is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Assi is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Familial Colorectal Cancer, Colorectal Cancer, and Fibrolamellar Carcinoma.
His clinical research consists of co-authoring 20 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Neuroendocrine Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
88 E Newton St, Evans 124, Boston, MA 02118
1 Boston Medical Ctr Pl, Boston, MA 02118
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Evans Medical Foundation Inc
Matthew Kulke is an Oncologist in Boston, Massachusetts. Dr. Kulke is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Liver Embolization. Dr. Kulke is currently accepting new patients.
The General Hospital Corporation
David Ryan is an Oncologist in Boston, Massachusetts. Dr. Ryan is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Tissue Biopsy, and Pancreaticoduodenectomy. Dr. Ryan is currently accepting new patients.
The General Hospital Corporation
Lawrence Blaszkowsky is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Blaszkowsky is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Neuroendocrine TumorDr. Assi isDistinguished. Learn about Neuroendocrine Tumor.
- Advanced
- Colorectal CancerDr. Assi isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Assi isAdvanced. Learn about Familial Colorectal Cancer.
- Fibrolamellar CarcinomaDr. Assi isAdvanced. Learn about Fibrolamellar Carcinoma.
- Experienced
- Anal CancerDr. Assi isExperienced. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Familial Pancreatic CancerDr. Assi isExperienced. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Assi isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Assi isExperienced. Learn about Gallbladder Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)